Subscribe To
Advanced wound care market size will be worth us$ 15.93 billion by 2032 : fact.mr study
Increased prevalence of Chronic and acute Wounds to Boost the Prospects For the Advanced Wound Care mar...
August 24, 2023, 9:00 am
China’s crisis of confidence
China’s economy needs active intervention by policy makers. If timely and articulated well, growth can outperform. China’s economy continues to ma...
August 23, 2023, 3:10 am
Anebulo (aneb) gains on positive fda response for aneb-001
Anebulo (ANEB) gains on positive FDA response for the phase III development of its lead candidate ANEB-001 for treating patients with ...
August 22, 2023, 11:17 am
Vincerx pharma receives fda clearance for early-stage leukemia trial
Vincerx Pharma shares moved higher after the biopharmaceutical company announced it has received Investigational New Drug (IND) clearance from the U.S...
August 22, 2023, 10:09 am
Hca healthcare (hca) favors pullback providing another opportunity
HCA Healthcare, Inc., (HCA) provides health care services company in the United States. The company operates general & ...
August 21, 2023, 8:36 pm
Gilead sciences told by fda to pause patient enrollment in leukemia drug trials
Gilead Sciences, Inc. (NASDAQ:GILD) said the Food and Drug Administration (FDA) has put a clinical hold on its studies evaluating its investigation an...
August 21, 2023, 10:41 am
Gilead says fda hits pause on study of leukemia treatment
Gilead Sciences Inc. GILD, -0.81% said Monday that the U.S. Food and Drug Administration has put a partial clinical hold on U.S. studies evaluating a ...
August 21, 2023, 8:47 am
acute migraine treatment market predicted to reach usd 7 billion by 2031, recording over a 15% cagr says, transparency market research
There are several drugs and therapies available for treating acute migraines, which is a rapidly expand...
August 18, 2023, 10:30 am
Alpha tau announces robust long-term safety and efficacy data from multiple clinical trials of alpha dart
– 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate. – Two-year local rec...
August 17, 2023, 9:00 pm
Cardiac biomarkers market to accelerate at a cagr of 11%, reaching us$ 38 billion by 2033: fact.mr report
Rising cases of myocardial infarction and acute coronary syndrome are leading to the increasing demand ...
August 17, 2023, 7:00 am
Palisade bio reports second quarter 2023 financial results
– Company accelerating late-stage corporate development activities to in-license/acquire synergistic assets to build GI-focused pipeline – Strong ...
August 11, 2023, 12:05 pm
News corp looking to ai in a bid to slash costs after profits tumble 75%
News Corp (NASDAQ:NWS), the owner of the Sun and the Times newspapers, has reported a 75% decline in its annual profit and said it will roll out AI-ge...
August 11, 2023, 3:25 am
Kymera therapeutics - need more developments before making this a buy
Kymera Therapeutics' valuation is difficult to estimate due to lack of positive net income, making it a poor buy. The company received FDA Orphan Drug...
August 9, 2023, 4:21 pm
Spero therapeutics shares rise on fda approval of pivotal complicated uti trial
Spero Therapeutics shares soared after the clinical-stage biopharmaceutical company announced that it has received special protocol approval from the ...
July 31, 2023, 3:42 pm
What's in the cards for universal health (uhs) in q2 earnings?
Universal Health's (UHS) Q2 results are likely to benefit from higher patient volumes at its acute care...
July 21, 2023, 1:42 pm
Redhill biopharma's stock soars 10% after company gets u.s. funding to develop treatment for radiation sickness
RedHill Biopharma Ltd.'s stock RDHL, +1.65% soared 10% premarket after the company said it has received a further $1.7 million in U.S. government fund...
July 21, 2023, 7:32 am
Virios therapeutics announces positive data demonstrating improvement in multiple long-covid symptoms following treatment with a combination of valacyclovir and celecoxib in an exploratory, open-label
ATLANTA, July 17, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company fo...
July 17, 2023, 11:05 am
Seelos: 2 catalysts before end of 2023 make this a must watch
Results from Part 2 of the phase 2 registration-directed study, using SLS-002 for acute suicidal ideati...
July 12, 2023, 7:09 pm
Kura oncology: targeted aml therapy continues to deliver
Kura Oncology, Inc. has additional updated results released from the KOMET-001 study, as part of an oral late-breaker presentation shown on June 11, 2...
July 12, 2023, 4:23 pm
Moderna stock pops after company makes regulatory submissions in u.s., europe, switzerland and australia for its rsv vaccine
Moderna Inc.'s stock MRNA, +2.43% rose 3% Wednesday, after the company said it has made regulatory submissions in Europe, Switzerland and Australia fo...
July 5, 2023, 11:08 am
